PL2381786T3 - Dimetylosulfotlenkowy solwat darunawiru - Google Patents

Dimetylosulfotlenkowy solwat darunawiru

Info

Publication number: PL2381786T3
Authority: PL; Poland
Prior art keywords: darunavir; dimethylsulfoxide solvate; dimethylsulfoxide; solvate
Prior art date: 2009-01-29

Application number

PL09839083T

Other languages

English (en)

Inventor

Ehud Marom

Original Assignee

Mapi Pharma Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-01-29

Filing date

2009-12-08

Publication date

2015-06-30

2009-12-08 Application filed by Mapi Pharma Ltd filed Critical Mapi Pharma Ltd

2015-06-30 Publication of PL2381786T3 publication Critical patent/PL2381786T3/pl

Links

IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 title 2
CJBJHOAVZSMMDJ-HEXNFIEUSA-N darunavir Chemical compound C([C@@H]([C@H](O)CN(CC(C)C)S(=O)(=O)C=1C=CC(N)=CC=1)NC(=O)O[C@@H]1[C@@H]2CCO[C@@H]2OC1)C1=CC=CC=C1 CJBJHOAVZSMMDJ-HEXNFIEUSA-N 0.000 title 1
229960005107 darunavir Drugs 0.000 title 1
239000012453 solvate Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Virology (AREA)
Oncology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

PL09839083T 2009-01-29 2009-12-08 Dimetylosulfotlenkowy solwat darunawiru PL2381786T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US14805509P	2009-01-29	2009-01-29
US24281809P	2009-09-16	2009-09-16
EP09839083.4A EP2381786B1 (en)	2009-01-29	2009-12-08	Dimethylsulfoxide solvate of darunavir
PCT/IL2009/001158 WO2010086844A1 (en)	2009-01-29	2009-12-08	Polymorphs of darunavir

Publications (1)

Publication Number	Publication Date
PL2381786T3 true PL2381786T3 (pl)	2015-06-30

Family

ID=42395158

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL09839083T PL2381786T3 (pl)	2009-01-29	2009-12-08	Dimetylosulfotlenkowy solwat darunawiru

Country Status (11)

Country	Link
US (1)	US20120035142A1 (pl)
EP (2)	EP2381786B1 (pl)
CN (1)	CN102300465A (pl)
AU (1)	AU2009339140A1 (pl)
BR (1)	BRPI0924207A2 (pl)
CA (1)	CA2750774A1 (pl)
ES (1)	ES2532755T3 (pl)
IL (1)	IL246900A0 (pl)
MX (1)	MX2011007790A (pl)
PL (1)	PL2381786T3 (pl)
WO (1)	WO2010086844A1 (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8921415B2 (en)	2009-01-29	2014-12-30	Mapi Pharma Ltd.	Polymorphs of darunavir
WO2011048604A2 (en)	2009-09-17	2011-04-28	Matrix Laboratories Limited	An improved process for the preparation of darunavir
ES2546866T3 (es)	2009-12-16	2015-09-29	Hetero Research Foundation	Polimorfos de darunavir
EP2528923B1 (en)	2010-01-28	2014-07-30	Mapi Pharma Limited	Process for the preparation of darunavir and darunavir intermediates
WO2011141921A1 (en) *	2010-05-10	2011-11-17	Hetero Research Foundation	Darunavir compositions
EP2571355B1 (en)	2010-05-20	2016-09-07	Hetero Research Foundation	Crystalline hydrochloride salt of darunavir
EP2632270A1 (en) *	2010-10-28	2013-09-04	Mapi Pharma Limited	Polymorphs of febuxostat
WO2012107889A1 (en)	2011-02-10	2012-08-16	Ranbaxy Laboratories Limited	Process for the preparation of amorphous darunavir
WO2013114382A1 (en)	2011-12-05	2013-08-08	Mylan Laboratories Ltd	Crystalline darunavir
WO2013108105A2 (en)	2012-01-18	2013-07-25	Aurobindo Pharma Limited	Novel solvates of darunavir
WO2013189049A1 (zh) *	2012-06-20	2013-12-27	上海迪赛诺药业有限公司	制备达芦那韦无定形物的方法
CN103509031B (zh) *	2012-06-20	2016-04-27	上海迪赛诺药业有限公司	制备达芦那韦无定形物的方法
ES2848216T3 (es) *	2012-07-24	2021-08-05	Laurus Labs Ltd	Un proceso para la preparación de Darunavir
CN105315178B (zh) *	2014-07-09	2018-07-06	浙江九洲药业股份有限公司	达芦那韦相关物质及其制备方法
CN106854212A (zh)	2015-12-08	2017-06-16	浙江九洲药业股份有限公司	一种达芦那韦无定型的制备方法
CN107235987A (zh) *	2016-03-28	2017-10-10	浙江九洲药业股份有限公司	一种地瑞那韦甲醇溶剂化物及其制备方法和用途
CN108727401A (zh) *	2017-04-20	2018-11-02	盐城迪赛诺制药有限公司	达鲁那韦新晶型及其制备方法和应用
CN109632555B (zh) *	2018-12-28	2021-07-27	上海新黄河制药有限公司	一种富马酸福莫特罗无定型含量的动态蒸汽吸附分析方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5968942A (en)	1992-08-25	1999-10-19	G. D. Searle & Co.	α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
AU7669794A (en)	1993-08-24	1995-03-21	G.D. Searle & Co.	Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
NZ508855A (en) *	1998-06-19	2003-10-31	Vertex Pharma	Sulfonamide inhibitors of HIV aspartyl protease
JP4776775B2 (ja)	1998-06-23	2011-09-21	アメリカ合衆国	Ｈｉｖ感染哺乳動物を治療するための医薬組成物
ES2503551T5 (es)	2002-05-16	2021-10-28	Janssen Sciences Ireland Unlimited Co	Formas pseudopolimórficas de un inhibidor de la proteasa de VIH
JP2008520672A (ja) *	2004-11-16	2008-06-19	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	チプラナビルとダルナビルの共投与によるｈｉｖ感染症の治療方法
WO2011048604A2 (en) *	2009-09-17	2011-04-28	Matrix Laboratories Limited	An improved process for the preparation of darunavir

2009
- 2009-12-08 US US13/146,727 patent/US20120035142A1/en not_active Abandoned
- 2009-12-08 ES ES09839083.4T patent/ES2532755T3/es active Active
- 2009-12-08 AU AU2009339140A patent/AU2009339140A1/en not_active Abandoned
- 2009-12-08 CN CN2009801558012A patent/CN102300465A/zh active Pending
- 2009-12-08 CA CA2750774A patent/CA2750774A1/en not_active Abandoned
- 2009-12-08 BR BRPI0924207A patent/BRPI0924207A2/pt not_active IP Right Cessation
- 2009-12-08 PL PL09839083T patent/PL2381786T3/pl unknown
- 2009-12-08 EP EP09839083.4A patent/EP2381786B1/en not_active Not-in-force
- 2009-12-08 MX MX2011007790A patent/MX2011007790A/es not_active Application Discontinuation
- 2009-12-08 WO PCT/IL2009/001158 patent/WO2010086844A1/en not_active Ceased
- 2009-12-08 EP EP14187453.7A patent/EP2898776A1/en not_active Ceased
2016
- 2016-07-21 IL IL246900A patent/IL246900A0/en unknown

Also Published As

Publication number	Publication date
WO2010086844A1 (en)	2010-08-05
AU2009339140A1 (en)	2011-08-11
IL246900A0 (en)	2016-09-29
EP2381786A1 (en)	2011-11-02
ES2532755T3 (es)	2015-03-31
CA2750774A1 (en)	2010-08-05
MX2011007790A (es)	2011-11-18
CN102300465A (zh)	2011-12-28
US20120035142A1 (en)	2012-02-09
BRPI0924207A2 (pt)	2016-07-26
EP2381786A4 (en)	2012-06-20
EP2381786B1 (en)	2014-12-24
EP2898776A1 (en)	2015-07-29

Publication	Publication Date	Title
IL246900A0 (en)	2016-09-29	Polymorphs of Dronir
EP2513116A4 (en)	2013-05-08	POLYMORPH OF DARUNAVIR
IL217745A0 (en)	2012-03-29	Antiviral compounds and methods of making and using thereof
GB2473099B (en)	2012-04-18	Inspection of holes
ZA201202504B (en)	2013-06-26	Process for the preparation of calcobutrol
IL218882A0 (en)	2012-06-28	Tubular photobioreactor
ZA201206297B (en)	2013-06-26	Sorafenib dimethyl sulphoxide solvate
ZA201204365B (en)	2013-12-23	Darunavir polymorph and process for preparation thereof
PL2330326T3 (pl)	2014-11-28	Rurowy element konstrukcyjny
PL390042A1 (pl)	2011-07-04	Sposób wytwarzania kwasu chlebowego
PL388931A1 (pl)	2011-03-14	Sposób otrzymywania fluorokarbofunkcyjnych silseskwioksanów
GB2468936B (en)	2011-09-07	Chlorination of sucrose-6-esters
IL219138A0 (en)	2012-06-28	Process for the preparation of 4-sulfinyl-pyrazole derivatives
ZA201107813B (en)	2012-07-25	Novel solvate crystals
ZA201200751B (en)	2012-10-31	Fluorinated derivatives of 3-hydroxypyridin-4-ones
GB0922023D0 (en)	2010-02-03	Preparation of n-monofluoroalkyl compounds
EP2459540A4 (en)	2012-12-19	PREPARATION OF FIPAMEZOLE
GB0918923D0 (en)	2009-12-16	Aminothiazole derivatives
SI2387557T1 (sl)	2013-12-31	Postopek za pripravo N-(5-(3-dimetilamino-akriloil)-2-fluorofenil)-N-metil-acetamida
IL214275A0 (en)	2011-09-27	Polymorphs of darunavir
TWM371549U (en)	2010-01-01	Movable bathtub
GB0914896D0 (en)	2009-09-30	Moveable wall
GB0902062D0 (en)	2009-03-11	Moveable wall
TWM374127U (en)	2010-02-11	Structure of three-string Huqin
GB0915468D0 (en)	2009-10-07	Get me out of here